SANDOZ EFAVIRENZ/EMTRICITABINE/TENOFOVIR

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: f3151b0a9bbf5a11
Drug Approval Canada Name: SANDOZ EFAVIRENZ/EMTRICITABINE/TENOFOVIR
Product Name: SANDOZ EFAVIRENZ/EMTRICITABINE/TENOFOVIR
Status: Cancelled Post Market
Status Date: 2022-05-12
Original Market Date: 2019-09-30
Din: 02484676
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:18.08.20
Atc Original: J05AR06 EMTRICITABINE, TENOFOVIR DISOPROXIL AND EFAVIRENZ
Atc Name: j 05 ar 06
Aig Number: 0352327001
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

TENOFOVIR DISOPROXIL FUMARATE

300 MG

EFAVIRENZ

600 MG

EMTRICITABINE

200 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f3151b0a9bbf5a11

Type

Standard